Literature DB >> 21540834

AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II.

Raphael Rozenfeld1, Achla Gupta, Khatuna Gagnidze, Maribel P Lim, Ivone Gomes, Dinah Lee-Ramos, Natalia Nieto, Lakshmi A Devi.   

Abstract

The mechanism of G protein-coupled receptor (GPCR) signal integration is controversial. While GPCR assembly into hetero-oligomers facilitates signal integration of different receptor types, cross-talk between Gαi- and Gαq-coupled receptors is often thought to be oligomerization independent. In this study, we examined the mechanism of signal integration between the Gαi-coupled type I cannabinoid receptor (CB(1)R) and the Gαq-coupled AT1R. We find that these two receptors functionally interact, resulting in the potentiation of AT1R signalling and coupling of AT1R to multiple G proteins. Importantly, using several methods, that is, co-immunoprecipitation and resonance energy transfer assays, as well as receptor- and heteromer-selective antibodies, we show that AT1R and CB(1)R form receptor heteromers. We examined the physiological relevance of this interaction in hepatic stellate cells from ethanol-administered rats in which CB(1)R is upregulated. We found a significant upregulation of AT1R-CB(1)R heteromers and enhancement of angiotensin II-mediated signalling, as compared with cells from control animals. Moreover, blocking CB(1)R activity prevented angiotensin II-mediated mitogenic signalling and profibrogenic gene expression. These results provide a molecular basis for the pivotal role of heteromer-dependent signal integration in pathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21540834      PMCID: PMC3116274          DOI: 10.1038/emboj.2011.139

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  Conformation state-sensitive antibodies to G-protein-coupled receptors.

Authors:  Achla Gupta; Fabien M Décaillot; Ivone Gomes; Oleg Tkalych; Andrea S Heimann; Emer S Ferro; Lakshmi A Devi
Journal:  J Biol Chem       Date:  2006-12-04       Impact factor: 5.157

2.  Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling.

Authors:  Andreas Breit; Khatuna Gagnidze; Lakshmi A Devi; Monique Lagacé; Michel Bouvier
Journal:  Mol Pharmacol       Date:  2006-05-08       Impact factor: 4.436

3.  Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?

Authors:  Christopher S Kearn; Katherine Blake-Palmer; Emma Daniel; Ken Mackie; Michelle Glass
Journal:  Mol Pharmacol       Date:  2005-02-14       Impact factor: 4.436

4.  CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function.

Authors:  Vedat Tiyerili; Sebastian Zimmer; Suzin Jung; Kerstin Wassmann; Claas P Naehle; Dieter Lütjohann; Andreas Zimmer; Georg Nickenig; Sven Wassmann
Journal:  Basic Res Cardiol       Date:  2010-04-02       Impact factor: 17.165

5.  Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension.

Authors:  Said AbdAlla; Ahmed Abdel-Baset; Heinz Lother; Adel el Massiery; Ursula Quitterer
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

6.  CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.

Authors:  Fatima Teixeira-Clerc; Boris Julien; Pascale Grenard; Jeanne Tran Van Nhieu; Vanessa Deveaux; Liying Li; Valérie Serriere-Lanneau; Catherine Ledent; Ariane Mallat; Sophie Lotersztajn
Journal:  Nat Med       Date:  2006-05-21       Impact factor: 53.440

7.  Absence of angiotensin II type 1 receptor gene mutations in human adrenal tumors.

Authors:  R Sachse; X J Shao; A Rico; U Finckh; A Rolfs; M Reincke; J Hensen
Journal:  Eur J Endocrinol       Date:  1997-09       Impact factor: 6.664

Review 8.  Angiotensin II receptors: protein and gene structures, expression and potential pathological involvements.

Authors:  E Clauser; K M Curnow; E Davies; S Conchon; B Teutsch; B Vianello; C Monnot; P Corvol
Journal:  Eur J Endocrinol       Date:  1996-04       Impact factor: 6.664

9.  A role for transmembrane domains V and VI in ligand binding and maturation of the angiotensin II AT1 receptor.

Authors:  Graciela C Pignatari; Raphael Rozenfeld; Emer S Ferro; Laerte Oliveira; Antonio C M Paiva; Lakshmi A Devi
Journal:  Biol Chem       Date:  2006-03       Impact factor: 3.915

10.  Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function.

Authors:  James Ellis; John D Pediani; Meritxell Canals; Sandra Milasta; Graeme Milligan
Journal:  J Biol Chem       Date:  2006-10-02       Impact factor: 5.157

View more
  61 in total

Review 1.  Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action.

Authors:  Pál Gyombolai; Dorottya Pap; Gábor Turu; Kevin J Catt; György Bagdy; László Hunyady
Journal:  Mol Cell Endocrinol       Date:  2011-11-02       Impact factor: 4.102

2.  Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface.

Authors:  Chantevy Pou; Clotilde Mannoury la Cour; Leigh A Stoddart; Mark J Millan; Graeme Milligan
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

3.  Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.

Authors:  Mohanraj Rajesh; Sándor Bátkai; Malek Kechrid; Partha Mukhopadhyay; Wen-Shin Lee; Béla Horváth; Eileen Holovac; Resat Cinar; Lucas Liaudet; Ken Mackie; György Haskó; Pál Pacher
Journal:  Diabetes       Date:  2012-02-07       Impact factor: 9.461

4.  Cannabinoid receptors CB1 and CB2 form functional heteromers in brain.

Authors:  Lucía Callén; Estefanía Moreno; Pedro Barroso-Chinea; David Moreno-Delgado; Antoni Cortés; Josefa Mallol; Vicent Casadó; José Luis Lanciego; Rafael Franco; Carmen Lluis; Enric I Canela; Peter J McCormick
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

5.  Receptor-specific crosstalk between prostanoid E receptor 3 and bombesin receptor subtype 3.

Authors:  Yan Zhang; Yanfang Liu; Lehao Wu; Chao Fan; Zhiwei Wang; Xiuli Zhang; Amal Alachkar; Xinmiao Liang; Olivier Civelli
Journal:  FASEB J       Date:  2018-01-22       Impact factor: 5.191

6.  Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A.

Authors:  Richard J Ward; John D Pediani; Graeme Milligan
Journal:  J Biol Chem       Date:  2011-09-09       Impact factor: 5.157

7.  Alterations in the Medullary Endocannabinoid System Contribute to Age-related Impairment of Baroreflex Sensitivity.

Authors:  Chris L Schaich; Hossam A Shaltout; Megan Grabenauer; Brian F Thomas; Patricia E Gallagher; Allyn C Howlett; Debra I Diz
Journal:  J Cardiovasc Pharmacol       Date:  2015-05       Impact factor: 3.105

Review 8.  Cannabinoid Receptors in Diabetic Kidney Disease.

Authors:  F Barutta; R Mastrocola; S Bellini; G Bruno; Gabriella Gruden
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

9.  GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding.

Authors:  Ivone Gomes; Dipendra K Aryal; Jonathan H Wardman; Achla Gupta; Khatuna Gagnidze; Ramona M Rodriguiz; Sanjai Kumar; William C Wetsel; John E Pintar; Lloyd D Fricker; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

10.  Detection of Receptor Heteromerization Using In Situ Proximity Ligation Assay.

Authors:  Ivone Gomes; Salvador Sierra; Lakshmi A Devi
Journal:  Curr Protoc Pharmacol       Date:  2016-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.